Intuitive Surgical shows no slowing
This article was originally published in The Gray Sheet
Growth of robotic surgery systems firm continues to soar with second quarter sales of $87 mil., up 65% from the prior-year period, driven by strong performance from Intuitive Surgical's gynecologic sector, which became its second largest surgical segment. Hysterectomy was the fastest growing procedure, VP-Business Development & Strategic Planning Aleks Cukic noted during firm's Q2 earnings call July 26. The largest gainer two years running on "The Gray Sheet" OTC index, Intuitive shipped 39 of its million-dollar-plus da Vinci systems during the quarter, bringing the number of worldwide installations to 467 (1"The Gray Sheet" Jan. 23, 2006, p. 13)...
You may also be interested in...
NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.